Luvox: Targeted Serotonin Reuptake Inhibition for OCD Relief
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.15 | $94.36 (0%) | 🛒 Add to cart |
| 60 | $2.28 | $188.72 $136.52 (28%) | 🛒 Add to cart |
| 90 | $1.97 | $283.09 $177.68 (37%) | 🛒 Add to cart |
| 120 | $1.84 | $377.45 $220.85 (41%) | 🛒 Add to cart |
| 180 | $1.69 | $566.17 $304.17 (46%) | 🛒 Add to cart |
| 270 | $1.59
Best per pill | $849.26 $428.65 (50%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.81 | $54.21 (0%) | 🛒 Add to cart |
| 60 | $1.37 | $108.42 $82.32 (24%) | 🛒 Add to cart |
| 90 | $1.23 | $162.62 $110.42 (32%) | 🛒 Add to cart |
| 120 | $1.15 | $216.83 $138.53 (36%) | 🛒 Add to cart |
| 180 | $1.08 | $325.25 $194.75 (40%) | 🛒 Add to cart |
| 270 | $1.03 | $487.87 $279.07 (43%) | 🛒 Add to cart |
| 360 | $1.00
Best per pill | $650.50 $361.39 (44%) | 🛒 Add to cart |
Synonyms | |||
Luvox (fluvoxamine) is a selective serotonin reuptake inhibitor (SSRI) specifically indicated for the treatment of obsessive-compulsive disorder (OCD) in adults and children. Developed with a distinct pharmacological profile, it offers a specialized approach to modulating serotonin pathways implicated in obsessive thoughts and compulsive behaviors. Its approval and clinical use are backed by extensive research demonstrating efficacy in reducing the severity and frequency of OCD symptoms. Medical professionals value Luvox for its targeted action and established safety profile when administered under appropriate supervision.
Features
- Active ingredient: Fluvoxamine maleate
- Available in 25 mg, 50 mg, and 100 mg tablet strengths
- Selective serotonin reuptake inhibitor (SSRI) class
- FDA-approved for obsessive-compulsive disorder (OCD)
- Also used off-label for social anxiety disorder, depression, and panic disorder
- Typically administered orally, once daily at bedtime or in divided doses
- Bioavailability of approximately 53%
- Half-life of approximately 15–22 hours
- Metabolized primarily in the liver via CYP450 enzymes
Benefits
- Reduces frequency and intensity of obsessive thoughts and compulsive rituals in OCD
- Helps restore functional daily living and improves quality of life
- May alleviate symptoms of co-occurring anxiety or depression
- Supports long-term management with a well-tolerated side effect profile for many patients
- Available in multiple dosages for individualized titration
- Backed by decades of clinical use and research in psychiatric practice
Common use
Luvox is primarily prescribed for the treatment of obsessive-compulsive disorder in both adult and pediatric populations (ages 8 and older). It is also used off-label for conditions such as social anxiety disorder, major depressive disorder, panic disorder, and post-traumatic stress disorder. In some cases, it may be utilized to manage symptoms of body dysmorphic disorder or eating disorders. Its use is always determined by a healthcare provider based on individual patient presentation, medical history, and treatment goals.
Dosage and direction
Dosage must be individualized under medical supervision. For adults with OCD, the recommended starting dose is 50 mg once daily at bedtime, gradually increased by 50 mg every 4–7 days as tolerated. The therapeutic range typically falls between 100–300 mg per day, administered in divided doses or as a single nightly dose. Doses exceeding 100 mg daily should be divided, with the larger portion administered at bedtime. For pediatric patients (ages 8–17), the starting dose is 25 mg daily, titrated cautiously to a maximum of 200 mg daily. Tablets should be swallowed whole with water, with or without food.
Precautions
Patients should be monitored for worsening depression, suicidal ideation, or unusual changes in behavior, especially during initial treatment or dosage adjustments. Use with caution in patients with a history of mania, seizures, liver impairment, or bleeding disorders. May cause drowsiness or dizziness—caution advised when driving or operating machinery. Avoid abrupt discontinuation; taper gradually under medical supervision to prevent withdrawal symptoms. Not recommended during pregnancy unless potential benefits outweigh risks. Use in elderly patients may require lower doses due to increased sensitivity.
Contraindications
Luvox is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to risk of serotonin syndrome. Contraindicated in those with known hypersensitivity to fluvoxamine or any component of the formulation. Should not be used concomitantly with thioridazine, pimozide, alosetron, or tizanidine due to potentially dangerous interactions. Not recommended in patients with uncontrolled narrow-angle glaucoma.
Possible side effect
Common side effects may include nausea, headache, drowsiness, insomnia, dry mouth, dizziness, constipation, sweating, loss of appetite, and nervousness. Sexual dysfunction such as decreased libido, delayed ejaculation, or anorgasmia may occur. Less frequently, patients may experience vomiting, diarrhea, tremor, or visual disturbances. Serious but rare side effects include serotonin syndrome, hyponatremia, abnormal bleeding, manic episodes, seizures, or angle-closure glaucoma. Any unusual or severe symptoms should be reported immediately to a healthcare provider.
Drug interaction
Luvox is a potent inhibitor of CYP1A2 and CYP2C19 enzymes and may interact with numerous medications. Significant interactions include: increased levels of clozapine, theophylline, methadone, warfarin, and certain benzodiazepines. Concurrent use with other serotonergic drugs (e.g., tramadol, linezolid, triptans) increases risk of serotonin syndrome. May enhance effects of anticoagulants and antiplatelet drugs. Avoid use with MAOIs, pimozide, thioridazine, alosetron, or tizanidine. Always inform your prescriber of all medications, supplements, and herbal products you are taking.
Missed dose
If a dose is missed, take it as soon as remembered unless it is close to the time of the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Consistent daily use is important for maintaining therapeutic effect; setting a reminder or using a pill organizer may help improve adherence.
Overdose
Symptoms of overdose may include nausea, vomiting, drowsiness, dizziness, tachycardia, and lethargy. Severe overdose may lead to coma, seizures, ECG changes, or serotonin syndrome. In case of suspected overdose, seek immediate medical attention or contact a poison control center. Treatment is supportive and may include activated charcoal, ECG monitoring, and symptomatic care. There is no specific antidote for fluvoxamine overdose.
Storage
Store at room temperature (20–25°C or 68–77°F) in a tightly closed container. Protect from light, moisture, and excessive heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Dispose of unused medication through a medicine take-back program or according to FDA-recommended disposal methods.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions regarding a medical condition or before starting any new treatment. Do not disregard or delay seeking professional medical advice based on information contained in this document.
Reviews
Clinical studies and patient reports generally reflect positive outcomes in the management of OCD symptoms with Luvox. Many users note significant reduction in obsessive thoughts and compulsive behaviors over several weeks of consistent use. Some report initial side effects such as nausea or drowsiness, which often subside with continued treatment. Healthcare providers frequently acknowledge its efficacy, especially in cases where other SSRIs have been ineffective. Individual experiences may vary, and results depend on proper diagnosis, dosing, and adherence to medical guidance.